Assessment of the effectiveness of golimumab 50-mg and 100-mg regimens in patients with rheumatoid arthritis in daily practice.

about

Assessment of the effectiveness of golimumab 50-mg and 100-mg regimens in patients with rheumatoid arthritis in daily practice.

Item

http://www.wikidata.org/entity/Q53654897

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Assessment of the effectivenes ...... d arthritis in daily practice.

@en

Assessment of the effectivenes ...... d arthritis in daily practice.

@nl

type

Item

label

Assessment of the effectivenes ...... d arthritis in daily practice.

@en

Assessment of the effectivenes ...... d arthritis in daily practice.

@nl

prefLabel

Assessment of the effectivenes ...... d arthritis in daily practice.

@en

Assessment of the effectivenes ...... d arthritis in daily practice.

@nl

P1476

Assessment of the effectivenes ...... d arthritis in daily practice.

@en

P2093

Atsuo Taniguchi

http://www.w3.org/2001/XMLSchema#string

Ayako Nakajima

http://www.w3.org/2001/XMLSchema#string

Daisuke Hoshi

http://www.w3.org/2001/XMLSchema#string

Eiichi Tanaka

http://www.w3.org/2001/XMLSchema#string

Eisuke Inoue

http://www.w3.org/2001/XMLSchema#string

Eri Sato

http://www.w3.org/2001/XMLSchema#string

Hisashi Yamanaka

http://www.w3.org/2001/XMLSchema#string

Kumi Shidara

http://www.w3.org/2001/XMLSchema#string

Moeko Ochiai

http://www.w3.org/2001/XMLSchema#string

Naoki Sugimoto

http://www.w3.org/2001/XMLSchema#string

P2860

Ten years with biologics: to whom do data on effectiveness and safety apply?

Effectiveness and safety of adalimumab in Japanese patients with rheumatoid arthritis: retrospective analyses of data collected during the first year of adalimumab treatment in routine clinical practice (HARMONY study).

Change in the discontinuation pattern of tumour necrosis factor antagonists in rheumatoid arthritis over 10 years: data from the Spanish registry BIOBADASER 2.0.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Treating rheumatoid arthritis to target: recommendations of an international task force.

Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study.

Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.

Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study.

The effects of golimumab on radiographic progression in rheumatoid arthritis: results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapy.

P304

528-533

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/14397595.2014.995892

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25536168

http://www.w3.org/2001/XMLSchema#string